Literature DB >> 29900942

Alteration of Bone Turnover Markers in Canonical Wingless Pathway in Patients With Ankylosing Spondylitis.

Jinxian Huang1, Guoxiang Song2, Zhihua Yin3, Zhongchao Fu3, Zhizhong Ye3.   

Abstract

OBJECTIVES: This study aims to determine the levels of bone turnover markers in canonical wingless pathway in patients with ankylosing spondylitis (AS) and the correlation with disease activity indexes. PATIENTS AND METHODS: We recruited a total of 43 AS patients (34 males, 8 females; mean age 36.8±9.3 years; range 22 to 62 years) and age- and sex-matched 42 healthy controls (32 males, 10 females; mean age 36.1±9.7; range 24 to 59 years). Serum levels of components of canonical wingless pathway including Dickkopf-1, glycogen synthase kinase-3β, β-catenin, alkaline phosphatase, and osteocalcin were detected using enzyme- linked immunosorbent assay method. All patients were assessed in terms of erythrocyte sedimentation rate, C-reactive protein, Bath Ankylosing Spondylitis Disease Activity Index, Bath Ankylosing Spondylitis Functional Index, Ankylosing Spondylitis Disease Activity Score, and the modified Stoke's Ankylosing Spondylitis Spine Score. Pearson's correlation test was used to analyze the correlation between serum bone turnover markers and clinical assessment indexes.
RESULTS: No significant difference was observed between AS patients and healthy controls for the levels of glycogen synthase kinase-3β, β-catenin, alkaline phosphatase, and osteocalcin, respectively (p>0.05). The level of Dickkopf-1 was significantly higher in AS patients (1914.5±407.8 pg/mL) than in healthy controls (1729.1±352.9 pg/mL) (p<0.05). There was no correlation between high Dickkopf-1 level and any of the clinical parameters contributing to inflammation or bone formation. However, the correlation between osteocalcin and disease duration was significant in AS patients (r=0.323, p=0.034).
CONCLUSION: Alteration of bone turnover markers in canonical wingless pathway was observed in AS. This might partially explain the complicated mechanism of bone formation in the disease.

Entities:  

Keywords:  Ankylosing spondylitis; bone turnover; canonical wingless pathway

Year:  2016        PMID: 29900942      PMCID: PMC5827846          DOI: 10.5606/ArchRheumatol.2016.5857

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  48 in total

1.  Bone turnover markers, anterior pituitary and gonadal hormones, and bone mass evaluation using quantitative computed tomography in ankylosing spondylitis.

Authors:  Abdellah El Maghraoui; Saida Tellal; Souad Chaouir; Khalil Lebbar; Ahmed Bezza; Abderrazak Nouijai; Lahsen Achemlal; Sanaa Bouhssain; El Mostapha Derouiche
Journal:  Clin Rheumatol       Date:  2004-12-08       Impact factor: 2.980

2.  The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis.

Authors:  Kwi Young Kang; Ji Hyeon Ju; Sung-Hwan Park; Ho-Youn Kim
Journal:  Rheumatology (Oxford)       Date:  2012-12-28       Impact factor: 7.580

3.  Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation.

Authors:  Grigorios T Sakellariou; Athanasios D Anastasilakis; Ilias Bisbinas; Dimitrios Oikonomou; Spyridon Gerou; Stergios A Polyzos; Fares E Sayegh
Journal:  Rheumatology (Oxford)       Date:  2014-10-27       Impact factor: 7.580

4.  Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures.

Authors:  D Mitra; D M Elvins; A J Collins
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

Review 5.  Clinical utility of serum sclerostin measurements.

Authors:  Bart L Clarke; Matthew T Drake
Journal:  Bonekey Rep       Date:  2013-06-05

6.  Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis.

Authors:  Heiner Appel; Gisela Ruiz-Heiland; Joachim Listing; Jochen Zwerina; Martin Herrmann; Ruediger Mueller; Hildrun Haibel; Xenofon Baraliakos; Axel Hempfing; Martin Rudwaleit; Joachim Sieper; Georg Schett
Journal:  Arthritis Rheum       Date:  2009-11

7.  Etanercept in the longterm treatment of patients with ankylosing spondylitis.

Authors:  Ben Dijkmans; Paul Emery; Markku Hakala; Marjatta Leirisalo-Repo; Emilio Martin Mola; Laurence Paolozzi; Carlo Salvarani; Raimon Sanmarti; Jean Sibilia; Joachim Sieper; Filip Van Den Bosch; Désirée van der Heijde; Sjef van der Linden; Joseph Wajdula
Journal:  J Rheumatol       Date:  2009-05-01       Impact factor: 4.666

8.  Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis.

Authors:  Dimitrios Daoussis; Stamatis-Nick C Liossis; Elena E Solomou; Anastasia Tsanaktsi; Konstadina Bounia; Maria Karampetsou; Georgios Yiannopoulos; Andrew P Andonopoulos
Journal:  Arthritis Rheum       Date:  2010-01

9.  Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.

Authors:  Ali Taylan; Ismail Sari; Baris Akinci; Safak Bilge; Didem Kozaci; Servet Akar; Ayfer Colak; Hulya Yalcin; Necati Gunay; Nurullah Akkoc
Journal:  BMC Musculoskelet Disord       Date:  2012-10-02       Impact factor: 2.362

10.  Bone and cartilage turnover markers, bone mineral density, and radiographic damage in men with ankylosing spondylitis.

Authors:  Min-Chan Park; Soo-Jin Chung; Yong-Beom Park; Soo-Kon Lee
Journal:  Yonsei Med J       Date:  2008-04-30       Impact factor: 2.759

View more
  2 in total

Review 1.  Bone Involvement in Patients with Spondyloarthropathies.

Authors:  Willem Lems; Corinne Miceli-Richard; Judith Haschka; Andrea Giusti; Gitte Lund Chistensen; Roland Kocijan; Nicolas Rosine; Niklas Rye Jørgensen; Gerolamo Bianchi; Christian Roux
Journal:  Calcif Tissue Int       Date:  2022-01-23       Impact factor: 4.333

Review 2.  Bone phenotypes in rheumatology - there is more to bone than just bone.

Authors:  Christian S Thudium; Signe Holm Nielsen; Samra Sardar; Ali Mobasheri; Willem Evert van Spil; Rik Lories; Kim Henriksen; Anne-Christine Bay-Jensen; Morten A Karsdal
Journal:  BMC Musculoskelet Disord       Date:  2020-11-28       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.